This page uses content from Wikipedia and is licensed under CC BY-SA.


Desmethoxyfallypride (18F)
Desmethoxyfallypride 18F.svg
Clinical data
Other namesDMFP (18F)
  • N/A
ATC code
  • none
Legal status
Legal status
  • Research compound
PubChem CID
Chemical and physical data
Molar mass333.430818 g/mol g·mol−1
3D model (JSmol)

Desmethoxyfallypride is a moderate affinity dopamine D2 receptor/D3 receptor antagonist used in medical research, usually in the form of the radiopharmaceuticals desmethoxyfallypride or DMFP(18F)[1][2] and has been used in human studies[3][4] as a positron emission tomography (PET) radiotracer.


  1. ^ Mukherjee J, Yang ZY, Brown T, Roemer J, Cooper M (1996). "18F-desmethoxyfallypride: a fluorine-18 labeled radiotracer with properties similar to carbon-11 raclopride for PET imaging studies of dopamine D2 receptors". Life Sciences. 59 (8): 669–78. doi:10.1016/0024-3205(96)00348-7. PMID 8761017.
  2. ^ Leung, K. (2004). "(S)-N-((1-Allyl-2-pyrrolidinyl)methyl)-5-(3-18Ffluoropropyl)-2-methoxybenzamide". PMID 20641474. Cite journal requires |journal= (help)
  3. ^ Gründer G, Siessmeier T, Piel M, Vernaleken I, Buchholz HG, Zhou Y, et al. (January 2003). "Quantification of D2-like dopamine receptors in the human brain with 18F-desmethoxyfallypride". Journal of Nuclear Medicine. 44 (1): 109–16. PMID 12515884.
  4. ^ Siessmeier T, Zhou Y, Buchholz HG, Landvogt C, Vernaleken I, Piel M, et al. (June 2005). "Parametric mapping of binding in human brain of D2 receptor ligands of different affinities". Journal of Nuclear Medicine. 46 (6): 964–72. PMID 15937307.

External links